Interim Position Statement for Tirzepatide for managing overweight and obesity (IMOC approved)

The  Interim Position Statement for Tirzepatide for managing overweight and obesity can be found under the ‘South Yorkshire IMOC Guidance documents’ blue drop down header tab, on the South Yorkshire IMOC section of the ICB website:

South Yorkshire Integrated Medicines Optimisation Committee :: South Yorkshire I.C.B

  • Clinical support group
    • Endocrine and Diabetes

Do you want to add this to your CPD record?

Did you find this page helpful?